Skip to main content

Healthy Infants

3
Pipeline Programs
4
Companies
5
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
2
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Innovation Pharmaceuticals
2 programs
1
1
Powder based infant formulaPhase 31 trial
Regular non-hydrolysed cow's milkPhase 21 trial
Active Trials
NCT01507935Withdrawn0Est. Nov 2012
NCT01515644Completed164Est. Feb 2013
Abbott
AbbottABBOTT PARK, IL
1 program
1
Control Study FormulaPhase 31 trial
Active Trials
NCT01699386Completed213Est. Dec 2000
IQVIA
IQVIADURHAM, NC
1 program
Control 1st age starter infant formulaN/A1 trial
Active Trials
NCT06073652Active Not Recruiting240Est. Sep 2027
Human BioSciences
Human BioSciencesWV - Martinsburg
1 program
Effects of Infant Formula Composition on Infant Feeding BehaviorsN/A1 trial
Active Trials
NCT00957892Completed55Est. Mar 2011

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
Innovation PharmaceuticalsPowder based infant formula
AbbottControl Study Formula
Innovation PharmaceuticalsRegular non-hydrolysed cow's milk
IQVIAControl 1st age starter infant formula
Human BioSciencesEffects of Infant Formula Composition on Infant Feeding Behaviors

Clinical Trials (5)

Total enrollment: 672 patients across 5 trials

NCT01515644Innovation PharmaceuticalsPowder based infant formula

Study on the Effect of Inulin in Infant Formula on Gut Health

Start: Oct 2011Est. completion: Feb 2013164 patients
Phase 3Completed
NCT01699386AbbottControl Study Formula

Growth of Infants Fed an Elemental Medical Food

Start: Apr 1999Est. completion: Dec 2000213 patients
Phase 3Completed
NCT01507935Innovation PharmaceuticalsRegular non-hydrolysed cow's milk

Colonisation Resistance Study

Start: Jan 2012Est. completion: Nov 20120
Phase 2Withdrawn
NCT06073652IQVIAControl 1st age starter infant formula

Starter Infant Formula With Synbiotics

Start: Jul 2023Est. completion: Sep 2027240 patients
N/AActive Not Recruiting
NCT00957892Human BioSciencesEffects of Infant Formula Composition on Infant Feeding Behaviors

Effects of Infant Formula Composition on Infant Feeding Behaviors

Start: May 2009Est. completion: Mar 201155 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 late-stage (Phase 3) programs, potential near-term approvals
4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.